NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.870
+0.005 (0.27%)
At close: Oct 9, 2025, 4:00 PM EDT
1.850
-0.020 (-1.07%)
After-hours: Oct 9, 2025, 7:49 PM EDT

NLS Pharmaceutics AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
83194316-
Upgrade
Market Cap Growth
31.87%-82.11%-55.33%161.62%--
Upgrade
Enterprise Value
5517429-
Upgrade
Last Close Price
1.862.1123.6051.6044.40-
Upgrade
PB Ratio
2.752.43-2.1713.0530.18-
Upgrade
P/TBV Ratio
2.73--13.0530.18-
Upgrade
Debt / Equity Ratio
---0.18---0.23
Upgrade
Quick Ratio
2.502.560.122.682.280.02
Upgrade
Current Ratio
2.772.690.232.752.380.03
Upgrade
Return on Equity (ROE)
----862.92%--
Upgrade
Return on Assets (ROA)
-75.98%-111.41%-132.68%-128.67%-212.52%-150.64%
Upgrade
Return on Capital (ROIC)
----506.19%--
Upgrade
Earnings Yield
-80.90%-57.87%-63.63%-38.52%-72.97%-
Upgrade
FCF Yield
-62.69%-124.80%-50.63%-32.41%-91.48%-
Upgrade
Buyback Yield / Dilution
-201.68%-61.70%-93.96%-65.38%-71.00%-1.75%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q